Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
In December 2019, COVID-19 epidemic was described in Wuhan, China, and the infection has spread widely affecting hundreds of thousands. Herein, an effort was made to identify commercially available drugs in order to repurpose them against coronavirus by the means of structure-based virtual screening...
Saved in:
Published in | Journal of biomolecular structure & dynamics Vol. 39; no. 8; pp. 2980 - 2992 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
24.05.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!